Hui Shen

4.1k citations
116 papers · 2.2k indexed · h-index 28
Topics
Antifungal resistance and susceptibility (15 papers)Rheumatoid Arthritis Research and Therapies (13 papers)Psoriasis: Treatment and Pathogenesis (11 papers)
Journals
SHILAP Revista de lepidopterologíaThe Journal of ImmunologyPLoS ONE
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Hui Shen

110 papers receiving 2.2k citations

Peers

Hui Shen
Comparison fields: 5 of 140
  • Immunology 723
  • Molecular Biology 557
  • Rheumatology 487
  • Oncology 466
  • Epidemiology 392
Replace Gabriel J. Robbie with:
Gabriel J. Robbie United States
Oliver M. Steinmetz Germany
Kyungja Han South Korea
Jun Saegusa Japan
Daniela Damiani Italy
Fleurette Abreo United States
Michel Goldman Belgium
Amit Gaggar United States
Brendan O’Sullivan Australia
Hui Shen relative to Gabriel J. Robbie United States Gabriel J. Robbie's profile →
Citations per field
00.5×1.5×
Gabriel J. Robbie · 1×
Citations per year

Countries citing papers authored by Hui Shen

Since Specialization
Citations

This map shows the geographic impact of Hui Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Shen more than expected).

Fields of papers citing papers by Hui Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Shen. The network helps show where Hui Shen may publish in the future.

Co-authorship network of co-authors of Hui Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Shen. A scholar is included among the top collaborators of Hui Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Shen. Hui Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 0
4 6
5 1
6 13
7 11
8 6
9 14
10 8
11 9
12 15
13 8
14 27
15 82
16 9
17 38
18 28
19 55
20 60

About Hui Shen

Hui Shen is a scholar working on Rheumatology, Microbiology and Immunology, having authored 116 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (15 papers), Rheumatoid Arthritis Research and Therapies (13 papers) and Psoriasis: Treatment and Pathogenesis (11 papers). The work is most often cited by research in Immunology (723 citations), Rheumatology (487 citations) and Oncology (466 citations). Hui Shen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jing Lu, Liping Xia, Divaker Choubey, Alex B. Lentsch, Ravichandran Panchanathan, Mao Mao An, Yuetian Yu, Richard J. Cook, Ye Tian and Zui Zou. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026